Integrating PET and Fluorescence Imaging with a Novel PSMA-ICG Conjugate for Prostate Cancer Management
Ga]Ga-XY-PSMA-ICG is a clinically translatable dual-modality probe, offering a promising strategy to enhance the precise diagnosis and management of prostate cancer and supporting its further clinical application.
Authors
- P T Liu
- Jie Yang (ORCID: https://orcid.org/0000-0003-4801-7162)
- Jiale Hou
- Liying Tang
- Yi Yang
- Ming Zhou
- Yi Cai
- Yongxiang Tang (ORCID: https://orcid.org/0000-0003-3987-8702)
- Shuo Hu (ORCID: https://orcid.org/0000-0003-0998-8943)
Institutions
- Central South University (CN)
- National Health and Family Planning Commission (CN)
- Prostate Cancer Research (GB)
- National Clinical Research (US)
- Prostate Cancer UK (GB)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- Molecular Pharmaceutics
- Published
- 2026-05-08
- DOI
- https://doi.org/10.1021/acs.molpharmaceut.5c01950
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- Science and Technology Program of Hunan Province
- National Postdoctoral Program for Innovative Talents